Delivery of IL-15 to PD-L1 Expressing Tumors with an Anti-PD-L1 IgM

Posted on March 24, 2021March 23, 2021 by jean kanerva

Cytokine-Based Cancer Immunotherapies Summit – March 24-25, 2021

Angus M. Sinclair, PhD, VP, Immuno-oncology Research
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

Posted in publications.